INVADE: a real-life primary care long-term intervention program for brain health - results from 2013 to 2020

被引:0
|
作者
Bickel, Horst [1 ]
Nimmrichter, Bernhard [2 ]
Puerner, Klaus [2 ]
Sander, Dirk [3 ]
Foerstl, Hans [4 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Klin Psychiat & Psychotherapie, Munich, Germany
[2] INVADE, Inst Versorgungsforsch, Baldham, Germany
[3] Benedictus Krankenhaus Tutzing & Feldafing, Klin Neurol Neurol Fruhrehabil & Weiterfuhrende Re, Tutzing, Germany
[4] Tech Univ Munich, Inst Geschichte & Ethik Med, Klinikum Rechts Isar, Munich, Germany
关键词
stroke; dementia; long-term care; prevention; general practitioner; PREVENTION; DEMENTIA; STROKE;
D O I
10.1055/a-2525-2794
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background The primary care prevention program INVADE (INtervention project on VAscular brain diseases and Dementia in the district of Ebersberg) is intended to prevent stroke and dementia through systematic detection and evidence-based treatment of modifiable vascular risk factors. The study reports on the results of an eight-year evaluation phase. Methods Longitudinal study with non-randomized control group. AOK-insured patients over the age of 50 from the Bavarian district of Ebersberg were invited to participate in the project. The control group consisted of AOK-insured individuals of the same age-group from the district of Dachau. Primary clinical endpoints (mortality and long-term care dependency) and secondary endpoints (inpatient treatment due to cerebrovascular diseases) were based on the administrative data from the AOK. Analyses were carried out according to the principle "intention to treat". Results The intervention group (n=10,663) included 39.7% of insured persons who had enrolled in the program. Significant advantages were observed in the intervention group compared to the control group (n=13,225). Mortality was reduced by 6%, the incidence of long-term care by 10% and the prevalence of long-term care by 18.6%. There were about 190 fewer deaths and 260 fewer new cases of long-term care dependency than expected over a period of eight years. The prevalence of care dependency decreased by 1,600 years. The frequency of hospital treatment for cerebrovascular diseases, however, did not differ between the groups. Conclusion Our results suggest that a real-life practice-based prevention program aimed at better control of vascular risk factors can possibly contribute to a reduction of care dependency and an increase in life expectancy.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Oxybutynin in primary hyperhidrosis: A long-term real-life study
    Almeida, Ada Regina Trindade
    Ferrari, Fernanda
    Restrepo, Maria Victoria Suarez
    Rocha, Vanessa Barreto
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [2] Phosphate metabolism in primary hyperparathyroidism: a real-life long-term study
    Columbu, Carla
    Rendina, Domenico
    Gennari, Luigi
    Pugliese, Flavia
    Carnevale, Vincenzo
    Salcuni, Antonio Stefano
    Chiodini, Iacopo
    Battista, Claudia
    Tabacco, Patrizia
    Guarnieri, Vito
    Guglielmi, Giuseppe
    Eller-Vainicher, Cristina
    Cipriani, Cristiana
    Cuttitta, Antonello
    De Filippo, Gianpaolo
    Velluzzi, Fernanda
    Falchetti, Alberto
    Minisola, Salvatore
    Scillitani, Afredo
    Vescini, Fabio
    ENDOCRINE, 2025,
  • [3] Real-life challenge: training program on drug use and adolescence in primary health care
    de Aguiar Ximenes Pereira, Bruna Antunes
    Soares de Azevedo, Renata Cruz
    REVISTA DE SAUDE PUBLICA, 2019, 53
  • [4] Long-term results of primary nonfacilitated percutaneous coronary intervention in acute myocardial infarction patients transferred for up to 100 kilometers: Results of a real-life registry
    Karcz, M
    Bekta, P
    Kepka, C
    Ksiezycka, E
    Ciszewski, A
    Chmielak, Z
    Demkow, M
    Debski, A
    Ciszewski, M
    Witkowski, A
    Ruzyllo, W
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 275A - 275A
  • [5] Real-life digital signatures with long-term validity
    Martens, T
    SECURING ELECTRONIC BUSINESS PROCESSES, 2004, : 164 - 168
  • [6] Long-term adalimumab treatment of hidradenitis suppurativa: Results and practical insights from a real-life experience
    Bettoli, V.
    Manfredini, M.
    Calamo, G.
    Forconi, R.
    Bencivelli, D.
    Mantovani, L.
    Pellacani, G.
    Corazza, M.
    DERMATOLOGIC THERAPY, 2018, 31 (06)
  • [7] Long-Term Results of Transscleral Diode Laser Cyclophotocoagulation in Glaucoma: A Real-Life Study
    Sari, Cem
    Alagoz, Nese
    Omeroglu, Asena
    Cakir, Ihsan
    Pasaoglu, Isil
    Altan, Cigdem
    Yasar, Tekin
    JOURNAL OF GLAUCOMA, 2024, 33 (06) : 437 - 443
  • [8] Long-Term Evaluation of Intensified Ustekinumab in Crohn's Disease: Real-Life Results
    Molina Arriero, G.
    Gonzalez Furelos, T.
    Mauriz Barreiro, V.
    Echarri Piudo, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1039 - I1039
  • [9] Challenges in the long-term treatment of Schizophrenia - linking evidence to real-life clinical care
    Kapur, Shitij
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2011, 15 : 14 - 14
  • [10] Long-term effects of a primary health care intervention program for women:: Lower blood pressure and stable weight
    Björkelund, C
    Lissner, L
    Devine, C
    Lindroos, AK
    Palm, L
    Westerståhl, A
    FAMILY MEDICINE, 2000, 32 (04) : 246 - 251